ADAPs remain in crisis as demand grows for new drugs.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy* / Q000191:economics; D003363:Cost Control; D005380:Financing, Government; D015658:HIV Infections / Q000188:drug therapy* / Q000191:economics; D017320:HIV Protease Inhibitors / Q000191:economics / Q000600:supply & distribution*; D006297:Health Services Accessibility; D006801:Humans; D013219:State Government; D014481:United States
D017320:HIV Protease Inhibitors